Format

Send to

Choose Destination
Gene. 2014 Feb 10;535(2):365-9. doi: 10.1016/j.gene.2013.09.058. Epub 2013 Oct 17.

Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.

Author information

1
National Research Council, Institute of Biomedicine and Molecular Immunology "A. Monroy," 90146 Palermo, Italy.
2
Cardiology, Department of Clinical and Molecular Medicine, Sapienza University, 00189 Rome, Italy.
3
Cardiology, Department of Clinical and Molecular Medicine, Sapienza University, 00189 Rome, Italy. Electronic address: camillo.autore@uniroma1.it.

Abstract

Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of α-galactosidase A (α-gal A), a lysosomal hydrolase. This inactivation is responsible for the accumulation of undegraded glycosphingolipids in the lysosomes with subsequent cellular and microvascular dysfunction. Fabry is considered a rare disease, with an incidence of 1:40,000; however, there are good reasons to believe that it is often seen but rarely diagnosed. To date, more than 600 mutations have been identified in human GLA gene that are responsible for FD. We describe the case of a 54-year-old male patient, who presented with left ventricular hypertrophy, chronic renal failure and acroparaesthesias, which are considered to be specific features of FD. Clinical and instrumental investigations showed several cardiovascular manifestations. The molecular analysis of GLA gene revealed a novel mutation in the fifth exon, called N249K, and the enzymatic analysis showed no α-galactosidase A activity. Family screening detected the same mutation in some relatives and also the enzymatic analysis confirmed the diagnosis of FD. In conclusion, these data suggest that the N249K mutation may be associated with cardiac manifestations of FD combined with other classical features of the disease.

KEYWORDS:

Akt; Bp; CT; DNA complementary to RNA; ERK; FSGD; Fabry disease; GH; GHR; High resolution melting; Hypertrophic cardiomyopathy; JAK; Janus kinase; Mutation N249K; PI3K; PRLR; RACE; RT-PCR; SEM; SLR; STAT; TBE; UTR; base pair; cDNA; extracellular signal-regulated kinase; fish specific genome duplication; growth hormone; growth hormone receptor; mRNA; messenger RNA; nt; nucleotide; phosphatidylinositide 3-kinase; prolactin receptor; protein kinase B; rapid amplification of cDNA ends; reverse transcription polymerase chain reaction; signal transducer and activator of transcription; somatolactin receptor; standard error of the mean; threshold cycle number; tris–borate–ethylenediaminetetraacetic acid; untranslated region; α-Galactosidase A

PMID:
24140492
DOI:
10.1016/j.gene.2013.09.058
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center